|Traded as||NASDAQ: NVAX|
Russell 2000 Component
Number of employees
Novavax, Inc. is a clinical-stage vaccine company headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden. Novavax is a public company that trades under the symbol "NVAX".
In 2015 the company received an $89 million grant from the Bill & Melinda Gates Foundation to support the development of a vaccine against human respiratory syncytial virus for infants via maternal immunization.
In March 2015 the company completed a Phase I trial for its Ebola vaccine candidate.
In September 2016 the company announced that a Phase III trial of its RSV vaccine had failed to meet its endpoints, which caused its share price to fall from $8.34 to $1.40 and led the company to lay off 30% of its employees.
- "Novavax aims to rebound with restructuring, more trials". BioPharma Dive. Retrieved 2017-03-28.
- "Novavax, Inc. News Headlines". NASDAQ. Retrieved 8 September 2016.
- Taylor, Nick Paul (3 June 2013). "Novavax makes $30M bid for adjuvant business". FiercePharma. Retrieved 9 September 2016.
- "http://www.bizjournals.com/washington/blog/2015/09/gaithersburg-biotech-receives-grant-worth-up-to-89.html". www.bizjournals.com. Retrieved 2017-03-28. External link in
- "With promising RSV data in hand, Novavax wins $89M Gates grant for PhIII | FierceBiotech". www.fiercebiotech.com. Retrieved 2017-03-28.
- "Novavax RSV vaccine found safe for pregnant women, fetus". Reuters. 2016-09-29. Retrieved 2017-03-28.
- Herper, Matthew. "Gates Foundation Backs New Shot To Prevent Babies From Dying Of Pneumonia". Forbes. Retrieved 2017-03-28.
- "Novavax's Ebola vaccine shows promise in early-stage trial". Reuters. 2017-07-21. Retrieved 2017-03-28.
- "Novavax craters after Phase III RSV F vaccine failure; seeks path forward". www.fiercebiotech.com. Retrieved 2017-03-28.
- "Novavax hopes to revive RSV vaccine with a new phase 2 trial". www.fiercepharma.com. Retrieved 2017-03-28.
- "http://www.bizjournals.com/washington/news/2017/01/19/novavax-starts-new-clinical-trial-in-bid-to-prove.html". www.bizjournals.com. Retrieved 2017-03-28. External link in
- "Novavax takes RSV vaccine into Phase III ahead of schedule | FiercePharma". www.fiercepharma.com. Retrieved 2017-03-28.